As administrations change, cancer research stands in an unusually strong position, NCI Acting Director Douglas Lowy said in an interview with The Cancer Letter.
“We’re very fortunate that both Republicans and Democrats strongly support biomedical research in general, and cancer research in particular,” said Lowy said in a wide-ranging interview. “The leadership of the House and Senate appropriations subcommittees was responsible for the increase in FY16 for the NIH appropriation.”
Lowy spoke with Paul Goldberg, editor and publisher of The Cancer Letter, and Matthew Ong, a reporter with The Cancer Letter.
Read the full story on The Cancer Letter: http://cancerletter.com/articles/20170106_1